R.B. Healthcare Properties Limited 13370089 false 2022-12-01 2023-11-30 2023-11-30 The principal activity of the company is property investment. Digita Accounts Production Advanced 6.30.9574.0 true true 13370089 2022-12-01 2023-11-30 13370089 2023-11-30 13370089 bus:Consolidated 2023-11-30 13370089 core:RevaluationPropertyDeferredTax 2023-11-30 13370089 core:RetainedEarningsAccumulatedLosses 2023-11-30 13370089 core:ShareCapital 2023-11-30 13370089 core:CurrentFinancialInstruments core:WithinOneYear 2023-11-30 13370089 bus:SmallEntities 2022-12-01 2023-11-30 13370089 bus:Audited 2022-12-01 2023-11-30 13370089 bus:FullAccounts 2022-12-01 2023-11-30 13370089 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 13370089 bus:RegisteredOffice 2022-12-01 2023-11-30 13370089 bus:Director1 2022-12-01 2023-11-30 13370089 bus:Director2 2022-12-01 2023-11-30 13370089 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 13370089 core:UKTax 2022-12-01 2023-11-30 13370089 countries:EnglandWales 2022-12-01 2023-11-30 13370089 2022-11-30 13370089 2021-12-01 2022-11-30 13370089 2022-11-30 13370089 core:RevaluationPropertyDeferredTax 2022-11-30 13370089 core:RetainedEarningsAccumulatedLosses 2022-11-30 13370089 core:ShareCapital 2022-11-30 13370089 core:CurrentFinancialInstruments core:WithinOneYear 2022-11-30 13370089 core:UKTax 2021-12-01 2022-11-30 iso4217:GBP xbrli:pure

Registration number: 13370089

Prepared for the registrar

R.B. Healthcare Properties Limited

Annual Report and Financial Statements

for the Year Ended 30 November 2023

 

R.B. Healthcare Properties Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 7

 

R.B. Healthcare Properties Limited

Company Information

Directors

S K Kochhar

R Bhatia

Registered office

Unit 20 Brookfield Trade Centre
Brookfield Drive
Liverpool
L9 7AS

Auditors

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

R.B. Healthcare Properties Limited

(Registration number: 13370089)
Balance Sheet as at 30 November 2023

Note

2023
 £

2022
 £

Fixed assets

 

Investment property

5

910,003

910,003

Current assets

 

Debtors

6

824

-

Cash at bank and in hand

 

15,370

-

 

16,194

-

Creditors: Amounts falling due within one year

7

(887,908)

(886,160)

Net current liabilities

 

(871,714)

(886,160)

Total assets less current liabilities

 

38,289

23,843

Deferred tax liabilities

9

(48,136)

(48,136)

Net liabilities

 

(9,847)

(24,293)

Capital and reserves

 

Called up share capital

1

1

Profit and loss account

(9,848)

(24,294)

Total equity

 

(9,847)

(24,293)

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 20 February 2025 and signed on its behalf by:
 


S K Kochhar
Director

 

R.B. Healthcare Properties Limited

Notes to the Financial Statements for the Year Ended 30 November 2023

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 20 Brookfield Trade Centre
Brookfield Drive
Liverpool
L9 7AS
United Kingdom

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Name of parent of group

These financial statements are consolidated in the financial statements of R.B. Healthcare Limited.

The financial statements of R.B. Healthcare Limited may be obtained from Unit 20 Brookfield Trade Centre, Brookfield Drive, Liverpool, L9 7AS.

Going concern

As disclosed in note 8 to the financial statements the company is party to a financial guarantee contract in relation to the bank borrowings of its parent company, R.B Healthcare Limited.

Following a challenging financial year, due to several operating challenges within the pharmacy sector including clawbacks of National Health Service (NHS) funding, inflationary pressure on medicines and staff costs, and the significant interest rate rises, the group breached its bank loan covenants during the year ended 30 November 2023 and subsequently.

The group’s management team promptly implemented an operational review after the year end, resulting in notable improvements. Key initiatives have included:

• A significant increase in NHS income streams, such as blood pressure services and NMS (New Medicine Service).
• A focus on reducing medicine costs through improved procurement strategies.
• Participation in the Pharmacy First service, which commenced on 1 February 2024, generating additional income.

These measures have collectively strengthened gross profit margins.

As a result of the covenant breaches, the group’s banking partner issued a reservation of rights letter in May 2024. Therefore, until such time as the covenant breaches are formally waived, the group’s bank borrowings, which at 30 November 2023 amounted to £10,076,996, are repayable on demand and are appropriately disclosed as amounts falling due within one year in the financial statements.

 

R.B. Healthcare Properties Limited

Notes to the Financial Statements for the Year Ended 30 November 2023 (continued)

 

2

Accounting policies (continued)

The group’s banking partner has remained highly supportive and, since the year end, has provided an overdraft facility of £1,000,000, agreed to a capital repayment holiday until 31 March 2025 on the bank loans and suspended the bank loan covenants until 30 November 2025, replacing those with a tracking EBITDA covenant.

The directors have prepared detailed cash flow forecasts for a period of not less than 12 months from the date of approval of these financial statements. These forecasts indicate that the group has sufficient facilities to meet its operational needs and is expected to meet covenant requirements.

The cash flow forecasts incorporate assumptions regarding NHS funding, private sector income, and operating costs. There are inherent uncertainties surrounding these assumptions, including the timing of cash inflows and outflows, and sensitivity analysis on those forecast could result in additional funding facilities being required.

The directors remain confident the group will continue to operate within its facilities and meet covenant requirements. On this basis, the directors consider it appropriate to prepare the financial statements of the company on a going concern basis.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for property rental in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax. Rental lease incentives are spread over the period of the lease term.

The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met.

Tax

The tax expense for the period comprises current tax and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

 

R.B. Healthcare Properties Limited

Notes to the Financial Statements for the Year Ended 30 November 2023 (continued)

 

2

Accounting policies (continued)

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually, using observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

Trade debtors

Trade debtors are amounts due in respect of rental income in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

 

R.B. Healthcare Properties Limited

Notes to the Financial Statements for the Year Ended 30 November 2023 (continued)

 

2

Accounting policies (continued)

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2022 - 0).

 

4

Taxation

Tax charged/(credited) in the profit and loss account

2023
 £

2022
 £

Current taxation

UK corporation tax

5,632

3,875

UK corporation tax adjustment to prior periods

(22)

22

5,610

3,897

 

5

Investment properties

£

At 1 December 2022

910,003

At 30 November 2023

910,003

The directors are of the opinion that the fair value of the properties at the balance sheet date has not changed significantly since the date of their acquisition in 2021.

 

6

Debtors

2023
 £

2022
 £

Trade debtors

824

-

 

824

-

 

R.B. Healthcare Properties Limited

Notes to the Financial Statements for the Year Ended 30 November 2023 (continued)

 

7

Creditors

2023
 £

2022
 £

Due within one year

Trade creditors

-

4,633

Amounts due to related parties

877,359

873,003

Other creditors

509

509

Accrued expenses

4,430

4,140

Corporation tax liability

5,610

3,875

887,908

886,160

 

8

Financial commitments, guarantees and contingencies


Financial guarantee contracts

The company is party to a financial guarantee contract in relation to the bank borrowings of its parent company, R.B Healthcare Limited, which at 30 November 2023 amounted to £10,076,996. These borrowings are secured by fixed and floating charges over the assets of the company and its parent company and impose a negative pledge which prohibits the company and its parent company from creating any security interests over the property pledged as security
 

 

9

Deferred tax

Deferred tax assets and liabilities

2023

Liability
£

Corporation tax on revaluation gain

48,136

48,136

2022

Liability
£

Corporation tax on revaluation gain

48,136

48,136

 

10

Audit report

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 21 February 2025 was Julian Gaskell, who signed for and on behalf of Hazlewoods LLP.